Zim Laboratories

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
71.41
0.41 (0.58%)
BSENSE

Dec 05

BSE+NSE Vol: 16.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Trident Lifeline
Gennex Lab.
Bafna Pharma.
Brooks Lab.
Zenotech Lab.
Lyka Labs
Valiant Laborato
Nectar Lifesci.
Zim Laboratories
Infinium Pharma
Sat Kartar
Why is Zim Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -6.74% CAGR growth in Operating Profits over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 6.55% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 6 consecutive quarters
  • PBT LESS OI(Q) At Rs -2.38 cr has Fallen at -245.12%
  • PAT(Q) At Rs -0.42 cr has Fallen at -117.6%
  • ROCE(HY) Lowest at 6.21%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -42.18% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zim Laboratories for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Zim Laboratories
-41.59%
-0.86
48.45%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.96%
EBIT Growth (5y)
-6.74%
EBIT to Interest (avg)
3.11
Debt to EBITDA (avg)
2.09
Net Debt to Equity (avg)
0.48
Sales to Capital Employed (avg)
1.24
Tax Ratio
40.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
9.05%
ROE (avg)
6.55%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
52
Industry P/E
34
Price to Book Value
1.37
EV to EBIT
28.76
EV to EBITDA
12.85
EV to Capital Employed
1.25
EV to Sales
1.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.35%
ROE (Latest)
2.62%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-15What is not working for the Company
PBT LESS OI(Q)

At Rs -2.38 cr has Fallen at -245.12%

PAT(Q)

At Rs -0.42 cr has Fallen at -117.6%

ROCE(HY)

Lowest at 6.21%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 1.45 cr

DEBT-EQUITY RATIO(HY)

Highest at 0.48 times

Loading Valuation Snapshot...
Here's what is not working for Zim Laboratories
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -2.38 cr has Fallen at -245.12%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -0.42 cr has Fallen at -117.6%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.45 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio - Half Yearly
Highest at 0.48 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Non Operating Income - Quarterly
Highest at Rs 2.04 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income